Farallon Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $561M | Buy |
1,383,241
+347,385
| +34% | +$141M | 2.42% | 11 |
|
|
2025
Q1 | $515M | Sell |
1,035,856
-197,400
| -16% | -$98.2M | 2.56% | 14 |
|
|
2024
Q4 | $642M | Buy |
1,233,256
+523,800
| +74% | +$272M | 2.87% | 8 |
|
|
2024
Q3 | $439M | Sell |
709,456
-29,700
| -4% | -$18.4M | 1.94% | 16 |
|
|
2024
Q2 | $409M | Sell |
739,156
-58,260
| -7% | -$32.2M | 1.76% | 15 |
|
|
2024
Q1 | $463M | Sell |
797,416
-405,715
| -34% | -$236M | 1.97% | 13 |
|
|
2023
Q4 | $639M | Buy |
1,203,131
+155,600
| +15% | +$82.6M | 2.93% | 4 |
|
|
2023
Q3 | $530M | Sell |
1,047,531
-196,128
| -16% | -$99.3M | 2.48% | 8 |
|
|
2023
Q2 | $649M | Buy |
1,243,659
+194,600
| +19% | +$102M | 3.26% | 4 |
|
|
2023
Q1 | $605M | Sell |
1,049,059
-112,900
| -10% | -$65.1M | 3.3% | 3 |
|
|
2022
Q4 | $640M | Buy |
1,161,959
+39,900
| +4% | +$22M | 3.78% | 2 |
|
|
2022
Q3 | $569M | Sell |
1,122,059
-120,400
| -10% | -$61.1M | 3.13% | 2 |
|
|
2022
Q2 | $675M | Buy |
1,242,459
+18,600
| +2% | +$10.1M | 3.66% | 2 |
|
|
2022
Q1 | $723M | Buy |
1,223,859
+250,900
| +26% | +$148M | 3.49% | 1 |
|
|
2021
Q4 | $649M | Sell |
972,959
-6,700
| -0.7% | -$4.47M | 3.24% | 5 |
|
|
2021
Q3 | $560M | Sell |
979,659
-364,419
| -27% | -$208M | 2.61% | 5 |
|
|
2021
Q2 | $678M | Buy |
1,344,078
+189,000
| +16% | +$95.3M | 2.77% | 4 |
|
|
2021
Q1 | $527M | Buy |
1,155,078
+40,830
| +4% | +$18.6M | 2.62% | 6 |
|
|
2020
Q4 | $519M | Buy |
1,114,248
+18,670
| +2% | +$8.7M | 3.12% | 4 |
|
|
2020
Q3 | $484M | Buy |
1,095,578
+26,073
| +2% | +$11.5M | 3.35% | 4 |
|
|
2020
Q2 | $388M | Sell |
1,069,505
-173,710
| -14% | -$62.9M | 3.1% | 6 |
|
|
2020
Q1 | $353M | Buy |
1,243,215
+390,055
| +46% | +$111M | 3.03% | 5 |
|
|
2019
Q4 | $277M | Buy |
+853,160
| New | +$277M | 1.87% | 15 |
|